Literature DB >> 3348802

Interactions of adriamycin with a calcium binding site.

R G Canada1, W Saway, E Thompson.   

Abstract

Terbium (Tb3+) luminescence has been used to investigate the interactions of adriamycin with a specific calcium binding protein, in the plasma membrane of GH3/B6 pituitary tumor cells. The luminescence intensity and lifetime of the Tb3+-GH3/B6 complex was quenched in the presence of adriamycin. According to Stern-Volmer analysis, the quenching of Tb3+-GH3/B6 luminescence was by both membrane bound adriamycin (Ka = 3.7 x 10(5) M-1) and free adriamycin (kq = 7.3 x 10(7) M-1 s-1). The data suggests that, the calcium binding site at the outer surface of the membrane is collisionally accessible to freely diffusing adriamycin; and, that the toxin receptor site is located near the bound metal ion.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3348802     DOI: 10.1016/s0006-291x(88)80334-6

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  Effects of adriamycin on chronic cardiotoxicity in selenium-deficient rats.

Authors:  C Coudray; S Mouhieddine; M J Richard; J Arnaud; J De Leiris; A Favier
Journal:  Basic Res Cardiol       Date:  1992 Mar-Apr       Impact factor: 17.165

2.  Lipid peroxidation products, and vitamin and trace element status in patients with cancer before and after chemotherapy, including adriamycin. A preliminary study.

Authors:  M Faber; C Coudray; H Hida; M Mousseau; A Favier
Journal:  Biol Trace Elem Res       Date:  1995 Jan-Mar       Impact factor: 3.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.